The Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Reynold A. Panettieri, Jr, MD, has affiliations with AstraZeneca, Boehringer-Ingelheim, Novartis, RIFM, Teva Pharmaceuticals Industries Ltd., Theravance Biopharma (Consulting Fees); AstraZeneca, Boehringer – Ingelheim, Genentech, Novartis, Teva Pharmaceutical Industries Ltd., Sanofi (Commercial Interests); AstraZeneca, Bristol Myers Squibb, Genentech, Gilead Sciences, Inc., MedImmune, OncoArendi Therapeutics, RIFM, Sanofi, Theratrophix LLC, Vertex (Contracted Research)
Planners and Managers
The PIM planners and managers have nothing to disclose. RMEI Medical Education, LLC planners and managers have nothing to disclose.
Facebook Comments